Detalles de la búsqueda
1.
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
PLoS Pathog
; 18(10): e1010885, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194628
2.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196614
3.
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trial.
Br J Clin Pharmacol
; 89(4): 1495-1501, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36437688
4.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Lancet
; 397(10282): 1351-1362, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798499
5.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet
; 396(10249): 467-478, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702298
6.
Enhanced T-Cell Maturation and Monocyte Aggregation Are Features of Cellular Inflammation in Human T-Lymphotropic Virus Type 1-Associated Myelopathy.
Clin Infect Dis
; 70(7): 1326-1335, 2020 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31063543
7.
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
Gastroenterology
; 164(2): 300-303.e3, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36270334
8.
T-cell immunophenotyping distinguishes active from latent tuberculosis.
J Infect Dis
; 208(6): 952-68, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23966657
9.
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.
Lancet Infect Dis
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615673
10.
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine.
Nat Commun
; 14(1): 8053, 2023 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052824
11.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Lancet Gastroenterol Hepatol
; 8(2): 145-156, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36481043
12.
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
EClinicalMedicine
; 56: 101823, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36684396
13.
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib.
J Crohns Colitis
; 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941436
14.
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
EClinicalMedicine
; 64: 102249, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842172
15.
Multicolor Flow Cytometry and High-Dimensional Data Analysis to Probe Complex Questions in Vaccinology.
Methods Mol Biol
; 2414: 433-447, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784050
16.
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens.
Front Immunol
; 13: 991509, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275655
17.
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial.
Clin Transl Sci
; 15(2): 524-534, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34670021
18.
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
EClinicalMedicine
; 44: 101262, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043093
19.
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
JCI Insight
; 7(7)2022 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192543
20.
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.
Immunother Adv
; 1(1): ltab015, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965490